We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTGM
5151
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$5K ﹤0.01%
430
+325
+310% +$3.05K
NDACU
5152
DELISTED
NightDragon Acquisition Corp. SCALE Units
NDACU
$5K ﹤0.01%
477
-5
-1% -$49
CRU
5153
DELISTED
Crucible Acquisition Corporation
CRU
$5K ﹤0.01%
488
+82
+20% +$805
FNHC
5154
DELISTED
FedNat Holding Company Common Stock
FNHC
$5K ﹤0.01%
16,332
+10,005
+158% +$5.46K
DTP
5155
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$5K ﹤0.01%
93
-66
-42% -$3.45K
LEAP.U
5156
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$5K ﹤0.01%
496
– –
ETTX
5157
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$5K ﹤0.01%
+2,426
New +$4.84K
MTRYU
5158
DELISTED
Monterey Innovation Acquisition Corp. Unit
MTRYU
$5K ﹤0.01%
450
– –
FIEE
5159
FiEE Inc
FIEE
$34.8M
$5K ﹤0.01%
518
+71
+16% +$1K
AEMD icon
5160
Aethlon Medical
AEMD
$1.55M
$4K ﹤0.01%
1
– –
AMPG icon
5161
AmpliTech
AMPG
$161M
$4K ﹤0.01%
2,007
-130
-6% -$295
ANIX icon
5162
Anixa Biosciences
ANIX
$111M
$4K ﹤0.01%
1,452
-4,531
-76% -$14.3K
APM
5163
DELISTED
Aptorum Group
APM
$4K ﹤0.01%
311
+212
+214% +$2.63K
ARKX icon
5164
ARK Space & Defense Innovation ETF
ARKX
$853M
$4K ﹤0.01%
266
+41
+18% +$620
ARMP icon
5165
Armata Pharmaceuticals
ARMP
$159M
$4K ﹤0.01%
+1,113
New +$4.83K
AWRE icon
5166
Aware
AWRE
$25.7M
$4K ﹤0.01%
1,649
-8,636
-84% -$22.9K
AXR icon
5167
AMREP Corp
AXR
$117M
$4K ﹤0.01%
+357
New +$4.37K
BATL icon
5168
Battalion Oil
BATL
$29.5M
$4K ﹤0.01%
415
+18
+5% +$289
BCV
5169
Bancroft Fund
BCV
$143M
$4K ﹤0.01%
201
– –
BDSX icon
5170
Biodesix
BDSX
$261M
$4K ﹤0.01%
108
-246
-69% -$8K
BELFA icon
5171
Bel Fuse Inc Class A
BELFA
$3.42B
$4K ﹤0.01%
168
+114
+211% +$2.48K
BNTC icon
5172
Benitec Biopharma
BNTC
$457M
$4K ﹤0.01%
226
+132
+140% +$3.07K
BRLT icon
5173
Brilliant Earth
BRLT
$21.9M
$4K ﹤0.01%
812
-979
-55% -$6.14K
BSV icon
5174
Vanguard Short-Term Bond ETF
BSV
$45.6B
$4K ﹤0.01%
47
-16
-25% -$1.23K
CADL icon
5175
Candel Therapeutics
CADL
$780M
$4K ﹤0.01%
1,219
+1,165
+2,157% +$4.67K
205 206
207
208 209

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.